Free Trial
OTCMKTS:RHHVF

Roche (RHHVF) Stock Price, News & Analysis

Roche logo
$333.18 -2.31 (-0.69%)
As of 06/13/2025 03:22 PM Eastern

About Roche Stock (OTCMKTS:RHHVF)

Key Stats

Today's Range
$327.44
$333.33
50-Day Range
$287.00
$335.49
52-Week Range
$266.59
$354.19
Volume
135 shs
Average Volume
8,142 shs
Market Capitalization
N/A
P/E Ratio
30.82
Dividend Yield
2.34%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Roche Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
1st Percentile Overall Score

RHHVF MarketRank™: 

Roche scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Roche.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Roche is 30.82, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.29.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Roche is 30.82, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.75.

  • Read more about Roche's valuation and earnings.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Roche has a short interest ratio ("days to cover") of 256.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Roche has recently increased by 8.63%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Roche pays a meaningful dividend of 3.21%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Roche does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Roche is 72.16%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Roche's dividend.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Roche has a short interest ratio ("days to cover") of 256.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Roche has recently increased by 8.63%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    1 people have searched for RHHVF on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Roche insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 29.01% of the stock of Roche is held by institutions.

  • Read more about Roche's insider trading history.
Receive RHHVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

RHHVF Stock News Headlines

Roche Holding AG (RHHVF) Receives a Buy from UBS
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
UBS Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)
Roche Holding AG (RHHVF) Receives a Buy from DZ BANK AG
See More Headlines

RHHVF Stock Analysis - Frequently Asked Questions

Roche's stock was trading at $280.00 at the start of the year. Since then, RHHVF stock has increased by 19.0% and is now trading at $333.18.
View the best growth stocks for 2025 here
.

Shares of RHHVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Ex-Dividend for 3/31 Dividend
3/27/2025
Record date for 3/31 Dividend
3/28/2025
Dividend Payable
3/31/2025
Today
6/15/2025
Next Earnings (Estimated)
7/24/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:RHHVF
CIK
N/A
Fax
N/A
Employees
103,605
Year Founded
N/A

Profitability

Trailing P/E Ratio
30.82
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (OTCMKTS:RHHVF) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners